The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging

被引:1
|
作者
Chow, Ji-Jian [1 ]
Leong, Kevin M. W. [1 ]
Shun-Shin, Matthew [1 ]
Jones, Sian [2 ]
Guttmann, Oliver P. [3 ]
Mohiddin, Saidi A. [3 ,4 ]
Lambiase, Pier [3 ]
Elliott, Perry M. [3 ]
Ormerod, Julian O. M. [5 ]
Koa-Wing, Michael [1 ]
Lefroy, David [2 ]
Lim, Phang Boon [1 ]
Linton, Nicholas W. F. [1 ]
Ng, Fu Siong [1 ]
Qureshi, Norman A. [2 ]
Whinnett, Zachary I. [1 ]
Peters, Nicholas S. [1 ]
Francis, Darrel P. [1 ]
Varnava, Amanda M. [1 ]
Kanagaratnam, Prapa [1 ]
机构
[1] Imperial Coll, Natl Heart & Lung Inst, London, England
[2] Imperial Coll Healthcare NHS Trust, Cardiol Dept, London, England
[3] Barts Heart Ctr, Cardiol Dept, London, England
[4] Queen Mary Univ London, Cardiol Dept, London, England
[5] Oxford Univ Hosp NHS Trust, Cardiol Dept, Oxford, England
关键词
hypertrophic cardiomyopathy; sudden death; electrocardiographic imaging; implantable defibrillator; risk stratification; SUDDEN CARDIAC DEATH; ACTION-POTENTIAL DURATIONS; EUROPEAN-SOCIETY; CARDIOLOGY; FRACTIONATION; COLLEGE; MODEL;
D O I
10.3389/fphys.2024.1428709
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. Methods: HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts. Subjects underwent exercise testing by non-invasive electrocardiographic imaging to estimate epicardial electrophysiology. Results: Visual inspection of reconstructed epicardial HCM maps revealed isolated patches of late activation time (AT), prolonged activation-recovery intervals (ARIs), as well as reversal of apico-basal trends in T-wave inversion and ARI compared to controls (p < 0.005 for all). AT and ARI were compared between groups. The pooled HCM group had longer mean AT (60.1 ms vs. 52.2 ms, p < 0.001), activation dispersion (55.2 ms vs. 48.6 ms, p = 0.026), and mean ARI (227 ms vs. 217 ms, p = 0.016) than structurally normal heart controls. HCM ventricular arrhythmia survivors could be differentiated from HCM patients without a personal history of life-threatening arrhythmia by longer mean AT (63.2 ms vs. 57.4 ms, p = 0.007), steeper activation gradients (0.45 ms/mm vs. 0.36 ms/mm, p = 0.011), and longer mean ARI (234.0 ms vs. 221.4 ms, p = 0.026). A logistic regression model including whole heart mean activation time and activation recovery interval could identify ventricular arrhythmia survivors from the HCM cohort, producing a C statistic of 0.76 (95% confidence interval 0.72-0.81), with an optimal sensitivity of 78.6% and a specificity of 79.8%. Discussion: The HCM epicardial electrotype is characterized by delayed, dispersed conduction and prolonged, dispersed activation-recovery intervals. Combination of electrophysiologic measures with logistic regression can improve differentiation over single variables. Future studies could test such models prospectively for risk stratification of sudden death due to HCM.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Arrhythmic risk stratification in hypertrophic cardiomyopathy: are we missing something?
    Gatzoulis, Konstantinos A.
    Georgopoulos, Stavros
    Anastasakis, Aris
    Antoniou, Christos-Konstantinos
    Arsenos, Petros
    Tsiachris, Dimitrios
    Dilaveris, Polychronis
    Sideris, Skevos
    Tousoulis, Dimitrios
    EUROPACE, 2021, 23 (04): : 648 - 649
  • [22] Myocardial Fibrosis Severity on Cardiac Magnetic Resonance Imaging Predicts Sustained Arrhythmic Events in Hypertrophic Cardiomyopathy
    Prinz, Christian
    Schwarz, Maria
    Ilic, Ivan
    Laser, Kai Thorsten
    Lehmann, Roman
    Prinz, Eva-Maria
    Bitter, Thomas
    Vogt, Juergen
    van Buuren, Frank
    Bogunovic, Nikola
    Horstkotte, Dieter
    Faber, Lothar
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (03) : 358 - 363
  • [23] Speckle tracking imaging in hypertrophic cardiomyopathy: Apowerful tool in search of an unfavorable substrate?
    Rigopoulos, A. G.
    Ali, M.
    Sakellaropoulos, S.
    Matiakis, M.
    Teren, M.
    Pantazis, A.
    Noutsias, M.
    HERZ, 2019, 44 (03) : 265 - 265
  • [24] MR IMAGING OF HYPERTROPHIC CARDIOMYOPATHY
    PARK, JH
    KIM, YM
    CHUNG, JW
    PARK, YB
    HAN, JK
    HAN, MC
    RADIOLOGY, 1992, 185 (02) : 441 - 446
  • [25] Discriminating hereditary transthyretin cardiomyopathy from hypertrophic cardiomyopathy using an echocardiographic and ECG based classification tree
    Gustafsson, S.
    Granasen, G.
    Wiklund, U.
    Gronlund, C.
    Suhr, O. B.
    Lindqvist, P.
    EUROPEAN HEART JOURNAL, 2014, 35 : 929 - 929
  • [26] Multimodality Imaging for Hypertrophic Cardiomyopathy
    Elona Rrapo Kaso
    Christopher M. Kramer
    Current Treatment Options in Cardiovascular Medicine, 2020, 22
  • [27] Integrated Imaging in Hypertrophic Cardiomyopathy
    Choudhury, Lubna
    Rigolin, Vera H.
    Bonow, Robert O.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (02): : 328 - 339
  • [28] Multimodality imaging of hypertrophic cardiomyopathy
    Dong, Tiffany
    Gilliland, Yvonne
    Kramer, Christopher M.
    Theodore, Abraham
    Desai, Milind
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 80 : 14 - 24
  • [29] Multimodality Imaging for Hypertrophic Cardiomyopathy
    Kaso, Elona Rrapo
    Kramer, Christopher M.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2020, 22 (10)
  • [30] ECG in hypertrophic cardiomyopathy - the facts. opinions, hypotheses
    Kurpesa, Malgorzata
    KARDIOLOGIA POLSKA, 2012, 70 (10) : 1071 - 1072